Search

Chong Shing Yung

from Hayward, CA
Age ~91
Get Report
Also known as:
Chong S Yung, Chong Oi Yung, Chor Chi Yung, Cheng Suhwa Yu, Chi Yung Chor, Shing Yung Chong, Yung Chong
Phone and address:
24123 Hesperian Blvd, Hayward, CA 94545
Related to:
Irene W Chen, 61Shun C Yu, 65Katrina Salta, 40Chun T Yu, 75
Connected to:
Alice A Yung, 81Amy T Yung, 56Anita M Yung, 50Arthur Yung, 59Bryant K Yung, 38Carroll J Yung, 68Cathleen Yung, 27Cathy Yung, 48Chee W Yung, 75Claire Yung, 32

Chong Yung Phones & Addresses

  • 24123 Hesperian Blvd, Hayward, CA 94545
  • 23772 Nevada Rd, Hayward, CA 94541
  • Fremont, CA
  • Alameda, CA

Resumes

Resumes

Chong Yung Photo 1

Senior Research Program Manager

View page
Location:
316 south Temple Dr, Milpitas, CA 95035
Industry:
Biotechnology
Work:
Agilent Technologies 2015 - 2018
Group Leader - Seahorse Cell Analysis Technician Development
Agilent Technologies 2015 - 2018
Senior Research Program Manager
Agilent Technologies Mar 2011 - 2015
Advanced Research Scientist at Agilent Technologies
Wyss Institute For Biologically Inspired Engineering 2009 - 2011
Postdoctoral Research Fellow
Boston Children's Hospital 2006 - 2010
Research Fellow In Surgery
Education:
Harvard Medical School 2006 - 2011
University of Maryland 1999 - 2005
Doctorates, Doctor of Philosophy, Chemical Engineering Uc Irvine 1991 - 1995
Bachelors, Bachelor of Science, Chemical Engineering Harvard University
Skills:
Molecular Biology
Cell Culture
Fluorescence Microscopy
Microscopy
Pcr
Biochemistry
Confocal Microscopy
Nanotechnology
Science
Western Blotting
Life Sciences
Lifesciences
Cell Biology
Biotechnology
Interests:
Science and Technology
Environment
Education
Children
Languages:
English
Chong Yung Photo 2

Chong Yung

View page

Publications

Us Patents

Device For Filtration Of Fluids Therethrough And Accompanying Method

View page
US Patent:
20120149021, Jun 14, 2012
Filed:
Jan 15, 2010
Appl. No.:
13/144572
Inventors:
Chong Wing Yung - San Jose CA, US
Donald E. Ingber - Boston MA, US
Jason O. Fiering - Boston MA, US
Mathew Varghese - Sunnyvale CA, US
Assignee:
The Charles Stark Draper Laboratory, Inc. - Cambridge MA
Children's Medical Center Corporation - Boston MA
International Classification:
B03C 1/02
C12Q 1/68
H01J 49/26
C12Q 1/18
C12M 1/42
G01N 33/53
C12Q 1/02
US Classification:
435 612, 210695, 210141, 210222, 422 69, 435 29, 435 32, 4352871, 4352872, 436501, 250282
Abstract:
A microfluidic device for separating target components from a source fluid includes one or more source channels connected to one or more collection channels by one or more transfer channels. The target components of the source fluid can be magnetic or bound to magnetic particles using a know binding agent. A source fluid containing magnetically bound target components can be pumped through the source channel of the microfluidic device. A magnetic field gradient can be applied to the source fluid in the source channel causing the magnetically bound target components to migrate through the transfer channel into the collection channel. The collection channel can include a collection fluid that is stagnant until a predefined volume of source fluid is processed or a predefined volume of target components accumulate in the collection channel, at which point collection fluid can be pumped into the collection channel to flush the target components out of the collection channel. The target components can be subsequently analyzed for detection and diagnosis.

Compounds And Methods For Crispr/Cas-Based Genome Editing By Homologous Recombination

View page
US Patent:
20170058298, Mar 2, 2017
Filed:
Aug 30, 2016
Appl. No.:
15/251235
Inventors:
- Santa Clara CA, US
Gusti Zeiner - Pacifica CA, US
Subhadeep Roy - Lafayette CO, US
Chong Wing Yung - San Jose CA, US
International Classification:
C12N 15/90
C12N 15/113
Abstract:
The present invention relates to guide RNAs comprising adaptor segments having one or more modifications, and their use in homologous recombination by CRISPR:Cas systems. The modified adaptor segments are resistant to degradation by RNaseH. The present invention also relates to a dual guide RNA strategy in which a first guide RNA directs a Cas enzyme to make a double-strand break at a first target sequence, and a second guide RNA comprises an adaptor segment attached to a donor polynucleotide, and binds a second target sequence that is offset from the first target sequence.

Dialysis Like Therapeutic (Dlt) Device

View page
US Patent:
20140220617, Aug 7, 2014
Filed:
Apr 2, 2012
Appl. No.:
14/007738
Inventors:
Chong Wing Yung - Milpitas CA, US
Karel Domansky - Charlestown MA, US
Richard Terry - Belmont MA, US
David Kalish - Needham MA, US
Alexa Schulte - Boston MA, US
Joo Hun Kang - Boston MA, US
Donald E. Ingber - Boston MA, US
Michael Super - Lexington MA, US
Ryan M. Cooper - Cambridge MA, US
Assignee:
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
International Classification:
C12Q 1/04
B03C 1/00
B01L 3/00
US Classification:
435 34, 422503, 210695
Abstract:
A dialysis like therapeutic (DLT) device is provided. The DLT device includes at least one source channel connected at least one collection channels by one or more transfer channels. Fluid contacting surface of the channels can be an anti-fouling surface such as slippery liquid-infused porous surface (SLIPS). Fluids can be flown at high flow rates through the channels. The target components of the source fluid can be magnetic or bound to magnetic particles using an affinity molecule. A source fluid containing magnetically bound target components can be pumped through the source channel of the microfluidic device. A magnetic field gradient can be applied to the source fluid in the source channel causing the magnetically bound target components to migrate through the transfer channel into the collection channel. The collection channel can include a collection fluid to flush the target components out of the collection channel. The target components can be subsequently analyzed for detection and diagnosis. The source channel and the collection channels of the microfluidic device are analogous to the splenic arterioles and venules, respectively; the transfer channels mimic the vascular sinusoids of the spleen where opsonized particles are retained. Thus, the device acts as a dialysis like therapeutic device by combining fluidics and magnetics.
Control profile
Chong Shing Yung from Hayward, CA, age ~91 Get Report